# Genomics Used to Improve DEpression Decisions

> **NCT02109939** · NA · COMPLETED · sponsor: **Assurex Health Inc.** · enrollment: 1398 (actual)

## Conditions studied

- Major Depressive Disorder (MDD)

## Interventions

- **GENETIC:** GeneSight Psychotropic

## Key facts

- **NCT ID:** NCT02109939
- **Lead sponsor:** Assurex Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-04-20
- **Final completion:** 2017-07-31
- **Target enrollment:** 1398 (ACTUAL)
- **Last updated:** 2020-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02109939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02109939, "Genomics Used to Improve DEpression Decisions". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT02109939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*